Cargando…

Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?

Cancer is the leading cause of death and has remained a big challenge for the scientific community. Because of the growing concerns, new therapeutic regimens are highly demanded to decrease the global burden. Despite advancements in chemotherapy, drug resistance is still a major hurdle to successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Anwar, Sirajudheen, Malik, Jonaid Ahmad, Ahmed, Sakeel, Kameshwar, Verma Abhishek, Alanazi, Jowaher, Alamri, Abdulwahab, Ahemad, Nafees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698579/
https://www.ncbi.nlm.nih.gov/pubmed/36431766
http://dx.doi.org/10.3390/molecules27227668
_version_ 1784838855472447488
author Anwar, Sirajudheen
Malik, Jonaid Ahmad
Ahmed, Sakeel
Kameshwar, Verma Abhishek
Alanazi, Jowaher
Alamri, Abdulwahab
Ahemad, Nafees
author_facet Anwar, Sirajudheen
Malik, Jonaid Ahmad
Ahmed, Sakeel
Kameshwar, Verma Abhishek
Alanazi, Jowaher
Alamri, Abdulwahab
Ahemad, Nafees
author_sort Anwar, Sirajudheen
collection PubMed
description Cancer is the leading cause of death and has remained a big challenge for the scientific community. Because of the growing concerns, new therapeutic regimens are highly demanded to decrease the global burden. Despite advancements in chemotherapy, drug resistance is still a major hurdle to successful treatment. The primary challenge should be identifying and developing appropriate therapeutics for cancer patients to improve their survival. Multiple pathways are dysregulated in cancers, including disturbance in cellular metabolism, cell cycle, apoptosis, or epigenetic alterations. Over the last two decades, natural products have been a major research interest due to their therapeutic potential in various ailments. Natural compounds seem to be an alternative option for cancer management. Natural substances derived from plants and marine sources have been shown to have anti-cancer activity in preclinical settings. They might be proved as a sword to kill cancerous cells. The present review attempted to consolidate the available information on natural compounds derived from plants and marine sources and their anti-cancer potential underlying EMT mechanisms.
format Online
Article
Text
id pubmed-9698579
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96985792022-11-26 Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics? Anwar, Sirajudheen Malik, Jonaid Ahmad Ahmed, Sakeel Kameshwar, Verma Abhishek Alanazi, Jowaher Alamri, Abdulwahab Ahemad, Nafees Molecules Review Cancer is the leading cause of death and has remained a big challenge for the scientific community. Because of the growing concerns, new therapeutic regimens are highly demanded to decrease the global burden. Despite advancements in chemotherapy, drug resistance is still a major hurdle to successful treatment. The primary challenge should be identifying and developing appropriate therapeutics for cancer patients to improve their survival. Multiple pathways are dysregulated in cancers, including disturbance in cellular metabolism, cell cycle, apoptosis, or epigenetic alterations. Over the last two decades, natural products have been a major research interest due to their therapeutic potential in various ailments. Natural compounds seem to be an alternative option for cancer management. Natural substances derived from plants and marine sources have been shown to have anti-cancer activity in preclinical settings. They might be proved as a sword to kill cancerous cells. The present review attempted to consolidate the available information on natural compounds derived from plants and marine sources and their anti-cancer potential underlying EMT mechanisms. MDPI 2022-11-08 /pmc/articles/PMC9698579/ /pubmed/36431766 http://dx.doi.org/10.3390/molecules27227668 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Anwar, Sirajudheen
Malik, Jonaid Ahmad
Ahmed, Sakeel
Kameshwar, Verma Abhishek
Alanazi, Jowaher
Alamri, Abdulwahab
Ahemad, Nafees
Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
title Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
title_full Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
title_fullStr Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
title_full_unstemmed Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
title_short Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
title_sort can natural products targeting emt serve as the future anticancer therapeutics?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698579/
https://www.ncbi.nlm.nih.gov/pubmed/36431766
http://dx.doi.org/10.3390/molecules27227668
work_keys_str_mv AT anwarsirajudheen cannaturalproductstargetingemtserveasthefutureanticancertherapeutics
AT malikjonaidahmad cannaturalproductstargetingemtserveasthefutureanticancertherapeutics
AT ahmedsakeel cannaturalproductstargetingemtserveasthefutureanticancertherapeutics
AT kameshwarvermaabhishek cannaturalproductstargetingemtserveasthefutureanticancertherapeutics
AT alanazijowaher cannaturalproductstargetingemtserveasthefutureanticancertherapeutics
AT alamriabdulwahab cannaturalproductstargetingemtserveasthefutureanticancertherapeutics
AT ahemadnafees cannaturalproductstargetingemtserveasthefutureanticancertherapeutics